A Costly Case of Grant Fraud

The National Science Foundation orders Northeastern University to repay $2.7 million for nine years of mismanaging a federal grant.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NODAR KHERKHEULIDZEIn the agency’s priciest grant fraud settlement ever, the National Science Foundation (NSF) has ordered Northeastern University in Boston to pay back $2.7 million for nearly a decade of mishandling a grant from the agency. The details of the fraud are murky, but at the center of the case is former Northeastern physicist Stephen Reucroft, who headed up the university’s participation at CERN, the European Organization for Nuclear Research, from 2001 to 2010. The civil settlement stated that Northeastern paid salaries without proper documentation and covered expenses through the grant based on fraudulent documentation, some of which may have been submitted by Reucroft. The university “approved and disbursed at least 26 advances, totaling approximately $8.4 million in NSF funds, to CERN team accounts without required verification of need and sufficient oversight,” according to the settlement.

“The conduct in question related to accounting and grant oversight,” Northeastern said in a statement quoted by The Chronicle of Higher Education. “The university self-reported the discrepancies to the funding agency, the National Science Foundation, as soon as they were discovered and fully cooperated with the agency’s review.”

Boston’s WCVB 5 reported that the university didn’t notify the NSF of Reucroft’s misappropriation until 2008, two years after it learned of the discrepancies. Reucroft told The Chronicle that he was never contacted about the case since his retirement from Northeastern in 2010. “I am at a loss to understand it,” he said. “I am also a bit surprised that I have not been involved in the process.”

But Reucroft and university officials had clashed prior to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies